Onderneming Evogene Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
EVGN
IL0011050551
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Agriculture
67,2
%
| 1 | 52,3 % | 4 | 67,2 % | +332,76% |
Industrial Applications
19,1
%
| 0 | 4,3 % | 1 | 19,1 % | +1.393,06% |
Human Health
8,6
%
| 1 | 30,6 % | 0 | 8,6 % | -5,07% |
Unallocated
5,1
%
| 0 | 12,8 % | 0 | 5,1 % | +34,11% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
65,0
%
| 1 | 51,0 % | 4 | 65,0 % | +329,15% |
Others
19,0
%
| 0 | 4,0 % | 1 | 19,0 % | +1.499,40% |
Israel
16,0
%
| 1 | 45,0 % | 1 | 16,0 % | +19,72% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01-01-02 |
Yaron Eldad
DFI | Director of Finance/CFO | 57 | 01-04-22 |
Mark Kapel
CTO | Chief Tech/Sci/R&D Officer | 48 | 01-01-05 |
Eyal Ronen
PRN | Corporate Officer/Principal | - | 01-06-22 |
Sassi Masliah
PRN | Corporate Officer/Principal | - | 01-01-11 |
Human Resources Officer | - | 01-01-15 | |
Nir Arbel
PRN | Corporate Officer/Principal | - | 01-08-21 |
Yisrael Gewirtz
AUD | Comptroller/Controller/Auditor | 47 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dan Falk
BRD | Director/Board Member | 79 | 17-11-21 |
Sarit Firon
CHM | Chairman | 58 | 11-08-16 |
Leon Recanati
BRD | Director/Board Member | 76 | 01-05-05 |
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01-01-02 |
Oded Shoseyov
BRD | Director/Board Member | 67 | 01-11-18 |
Nir Nimrodi
BRD | Director/Board Member | 55 | 01-09-22 |
Adrian Percy
BRD | Director/Board Member | 59 | 04-02-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 50 584 888 | 49 746 029 ( 98,34 %) | 0 | 98,34 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,86 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,66 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |